<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39346658</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Mortality in hospitalized SARS-CoV-2 patients with contemporaneous bacterial and fungal infections.</ArticleTitle><Pagination><StartPage>e142</StartPage><MedlinePgn>e142</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e142</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.424</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The interplay between SARS-CoV-2 and contemporaneous bacterial or fungal culture growth may have crucial implications for clinical outcomes of hospitalized patients. This study aimed to quantify the effect of microbiological culture positivity on mortality among hospitalized patients with SARS-CoV-2.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective cohort study, we included adult hospitalized patients from OPTUM COVID-19 specific data set, who tested positive for SARS-CoV-2 within 14 days of hospitalization between 01/20/2020 and 01/20/2022. We examined outcomes of individuals with organisms growing on cultures from the bloodstream infections (BSIs), urinary tract, and respiratory tract, and a composite of the three sites. We used propensity score matching on covariates included demographics, comorbidities, and hospitalization clinical parameters. In a sensitivity analysis, we included same covariates but excluded critical care variables such as length of stay, intensive care unit stays, mechanical ventilation, and extracorporeal membrane oxygenation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The cohort included 104,560 SARS-CoV-2 positive adult hospitalized patients across the United States. The unadjusted mortality odds increased significantly with BSIs (98.7%) and with growth on respiratory cultures (RC) (176.6%), but not with growth on urinary cultures (UC). Adjusted analyses showed that BSIs and positive RC independently contribute to mortality, even after accounting for critical care variables.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In SARS-CoV-2-positive hospitalized patients, positive bacterial and fungal microbiological cultures, especially BSIs and RC, are associated with an increased risk of mortality even after accounting for critical care variables associated with disease severity. These findings underscore the importance of stringent infection control and the effective management of secondary infections to improve patient outcomes.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hanna</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-0909-9396</Identifier><AffiliationInfo><Affiliation>Information Services, ECU Health, Greenville, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Most</LastName><ForeName>Zachary M</ForeName><Initials>ZM</Initials><Identifier Source="ORCID">0000-0001-7021-8951</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Lauren N</ForeName><Initials>LN</Initials><Identifier Source="ORCID">0000-0003-4000-9192</Identifier><AffiliationInfo><Affiliation>Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakene</LastName><ForeName>Abdi D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0009-0000-7270-0506</Identifier><AffiliationInfo><Affiliation>Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radunsky</LastName><ForeName>Alexander P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-9309-9043</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases &amp; Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Christoph U</ForeName><Initials>CU</Initials><Identifier Source="ORCID">0000-0001-9559-4646</Identifier><AffiliationInfo><Affiliation>Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>O'Donnell School of Public Health, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perl</LastName><ForeName>Trish M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0001-9539-2358</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases &amp; Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>O'Donnell School of Public Health, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medford</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-9814-8043</Identifier><AffiliationInfo><Affiliation>Information Services, ECU Health, Greenville, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors disclosed no related conflict of interest to the content of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>17</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39346658</ArticleId><ArticleId IdType="pmc">PMC11428019</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.424</ArticleId><ArticleId IdType="pii">S2732494X24004248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alqahtani A, Alamer E, Mir M, et al. Bacterial coinfections increase mortality of severely Ill COVID-19 patients in Saudi Arabia. Int J Environ Res Public Health 2022;19:2424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871991</ArticleId><ArticleId IdType="pubmed">35206609</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskaran V, Lawrence H, Lansbury LE, et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol 2021;70:001350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8289210</ArticleId><ArticleId IdType="pubmed">33861190</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderon M, Gysin G, Gujjar A, et al. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2023;23:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9828368</ArticleId><ArticleId IdType="pubmed">36624396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry R, Sreenath K, Batra P, et al. Atypical bacterial co-infections among patients with COVID-19: a study from India. J Med Virol 2022;94:303–309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661859</ArticleId><ArticleId IdType="pubmed">34491594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhu Q, Xiao Y, et al. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: an observational study. Clin Respir J 2021;15:815–825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250518</ArticleId><ArticleId IdType="pubmed">33818909</ArticleId></ArticleIdList></Reference><Reference><Citation>Coenen S, de la Court JR, Buis DTP, et al. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study. Antimicrob Resist Infect Control 2021;10:155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556861</ArticleId><ArticleId IdType="pubmed">34717761</ArticleId></ArticleIdList></Reference><Reference><Citation>Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection 2021;49:559–562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779094</ArticleId><ArticleId IdType="pubmed">33393065</ArticleId></ArticleIdList></Reference><Reference><Citation>Foschi C, Zignoli A, Gaibani P, et al. Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: conventional culture vs BioFire FilmArray pneumonia Plus panel. J Microbiol Methods 2021;186:106259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164500</ArticleId><ArticleId IdType="pubmed">34062210</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. COVID-19 researchers group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2021;27:83–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves Mendes Neto A, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol 2021;93:1489–1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461450</ArticleId><ArticleId IdType="pubmed">32808695</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Johansson N, Ternhag A, Abdel-Halim L, Hedlund J, Nauclér P. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect Dis 2022;22:108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802536</ArticleId><ArticleId IdType="pubmed">35100984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020;26:1395–1399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320692</ArticleId><ArticleId IdType="pubmed">32603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorda A, Gabler C, Blaschke A, et al. Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study. Infection 2024;52:105–115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10811098</ArticleId><ArticleId IdType="pubmed">37326938</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622–1629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81:266–275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Chang E, Jung J, et al. Bacterial co-infection and empirical antibacterial therapy in patients with COVID-19. J Korean Med Sci 2023;38:e37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886529</ArticleId><ArticleId IdType="pubmed">36718563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HH, Yaron D, Piraino AS, Kapelusznik L. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob 2021;20:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465781</ArticleId><ArticleId IdType="pubmed">34563202</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Herrero R, Sánchez-de Prada L, Tamayo-Velasco A, et al. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study. Eur J Public Health 2023;33:675–681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10393489</ArticleId><ArticleId IdType="pubmed">37087109</ArticleId></ArticleIdList></Reference><Reference><Citation>M Abd El-Halim R, Hafez H, Albahet I, Sherif B. Respiratory co-infections in COVID-19-positive patients. Eur J Med Res 2023;28:317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10474635</ArticleId><ArticleId IdType="pubmed">37660059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control 2020;15:Doc35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747008</ArticleId><ArticleId IdType="pubmed">33391970</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-García E, Puerta-Alcalde P, Letona L, et al. COVID-19-researcher group. Bacterial co-infection at hospital admission in patients with COVID-19. Int J Infect Dis 2022;118:197–202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896874</ArticleId><ArticleId IdType="pubmed">35257905</ArticleId></ArticleIdList></Reference><Reference><Citation>Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One 2021;16:e0251170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101968</ArticleId><ArticleId IdType="pubmed">33956882</ArticleId></ArticleIdList></Reference><Reference><Citation>Nori P, Cowman K, Chen V, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol 2021;42:84–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417979</ArticleId><ArticleId IdType="pubmed">32703320</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeidat H, El-Nasser Z, Amarin Z, Qablan A, Gharaibeh F. The impact of COVID-19 pandemic on healthcare associated infections: a teaching hospital experience. Medicine (Baltimore) 2023;102:e33488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10100630</ArticleId><ArticleId IdType="pubmed">37058033</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Patel K, Milucky J, et al. CDC COVID-NET surveillance team. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022. Influenza Other Respir Viruses 2023;17:e13107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981874</ArticleId><ArticleId IdType="pubmed">36875205</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MJ, Orihuela CJ, Harrod KS, et al. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit Care 2023;27:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9868503</ArticleId><ArticleId IdType="pubmed">36691080</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 2020;71:2459–2468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197596</ArticleId><ArticleId IdType="pubmed">32358954</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Fairfield CJ, Drake TM, et al. ISARIC4C investigators. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe 2021;2:e354–e365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172149</ArticleId><ArticleId IdType="pubmed">34100002</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoettler JJ, Sandrio S, Boesing C, et al. Bacterial co- or superinfection in patients treated in Intensive Care Unit with COVID-19- and influenza-associated pneumonia. Pathogens 2023;12:927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10385659</ArticleId><ArticleId IdType="pubmed">37513774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma B, Sreenivasan P, Biswal M, et al. Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: time to adhere to culture-based practices. Qatar Med J 2021;2021:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8555674</ArticleId><ArticleId IdType="pubmed">34745914</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G, Schiavone F, Pipitone G, Taglietti F, Petrosillo N. Antibiotics use in COVID-19 patients: a systematic literature review. J Clin Med 2022;11:7207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9739751</ArticleId><ArticleId IdType="pubmed">36498781</ArticleId></ArticleIdList></Reference><Reference><Citation>Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021;29:930–941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026275</ArticleId><ArticleId IdType="pubmed">33934980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Hua M, Liu X, et al. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit. Microbes Infect 2021;23:104806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933791</ArticleId><ArticleId IdType="pubmed">33684520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. Journal of Statistical Software 2011;42, 1–28.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>